HIV Prevention Trials Network

Studies

HPTN 057
A Phase I Open Label Trial of the Safety and Pharmacokinetics of Tenofovir Disoproxil Fumarate in HIV-1 Infected Pregnant Women and their Infants

 

Study Documents

The HPTN 057 study team has made the following study documents available.  New documents will be posted here as they become available.

 

HPTN 057 Protocol

 

Clarification Memos

 

 

HPTN 057 Study Specific Procedures Manual

  • HPTN 057 SSP Manual v 4.0 Zip File (in revision)

  • Change Log  (Word) (PDF) (in revision)

  • Front Matter

    • Inside Front Cover (Word) (PDF) (18 Feb 2010)

    • Acronym List (Word) (PDF) (18 Feb 2010)

  • Table of Contents (Word) (PDF) (24 Jun 2010))

  • Section 1  Introduction (Word) (PDF) (18 Feb 2010)

  • Section 2  Protocol (Word) (PDF) (18 Feb 2010)
  • Section 3  Documentation Requirements (Word) (PDF) (18 Feb 2010

  • Section 4  Participant Accrual (Word) (PDF) (18 Feb 2010

  • Section 5  Participant Follow-up (Word) (PDF) (18 Feb 2010)

  • Section 6  Visit Checklists (Word) (PDF) (18 Feb 2010)

  • Section 7  Retention (Word) (PDF) (18 Feb 2010)

  • Section 8  Study Product Considerations (Word) (PDF) (18 Feb 2010)

  • Section 9  Clinical and Counseling Procedures (Word) (PDF) (18 Feb 2010)

  • Section 10  Laboratory Procedures (Word) (PDF) (11 Mar 2010)

  • Section 11  Adverse Event Reporting and Safety Monitoring (Word) (PDF) (18 Feb 2010)

  • Section 12  DataFax (PDF) (18 Feb 2010)

  • Section 13 Reporting Plan (PDF) (22 Jun 2010)

HPTN 057 Case Report Forms

Please contact Lynda Emel at SCHARP to obtain the latest version of the HPTN 057 CRFs

HPTN 057 Study Implementation Documents and Resources

HPTN 057 Site-Specific Study Operating Procedures (SOPs)

HPTN 057 Safety Monitoring and Adverse Event Reporting

HPTN 057 Resources

 

 

Site Map | HPTN Disclaimer | Webmaster | ©2008 Family Health International